Delivery Order SPE2DB22D2211-SPE2DB25FSDNV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency awarded a $1,968.89 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,006.73 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and utilizes firm fixed price pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,450.76 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This non-competitive delivery order, issued on May 8, 2025, with an ultimate completion date of May 9, 2025, represents a firm fixed price transaction for pharmaceutical supply. The award was fulfilled by AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,738.76 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin, with an ultimate completion date of August 28, 2025. This non-competitive delivery order was issued under a firm fixed price arrangement, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a routine pharmaceutical procurement action...
- The Defense Logistics Agency awarded a delivery order valued at $2,045.60 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin on September 17, 2025, with completion targeted for September 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.03 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 unit/mL 3 mL insulin, with an ultimate completion date of August 6, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a single transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $1,500.72 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 unit/mL insulin in 3 mL formulations, with an ultimate completion date of September 5, 2025. This competitive award utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,252.93 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3mL vials, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor,...
- The Defense Logistics Agency awarded a $7,142.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin, with an ultimate completion date of September 8, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDNVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,406.25 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key provider within the federal pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/25/25 |